Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: A preliminary report [4]

Haematologica

Volumn 86, Issue 1, 2001, Pages 104-

  Leoni, F ^a   Ciolli, S ^a   Nozzoli, C ^a   Santini, V ^a   Fanci, R ^a   Ferrini, P R ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

AML; Elderly; Topotecan

Indexed keywords

CYTARABINE; ETOPOSIDE; FLUDARABINE; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MALE; PNEUMONIA; PROGNOSIS; REMISSION; SEPSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DISEASE-FREE SURVIVAL; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; REMISSION INDUCTION; TOPOTECAN; VIDARABINE;

EID: 0035136817     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Management of acute myeloid leukemia in elderly patients
2. Intensive remission chemotherapy in adults with acute myeloid leukemia
3. FLAG (fludarabine + high-dose cytarabine + G-CSF): An effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias
4. FLAG vs ICE as induction treatment for acute myeloid leukemia in the elderly
5. Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia
6. Minimum dose of fludarabine for the maximal modulation of ara-CTP in human leukemia blasts during therapy